Fennec Pharmaceuticals Inc.
FENC- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001211583
In the last 90 days, Fennec Pharmaceuticals Inc. insiders filed 0 open-market purchases and 5 sales; 105 institutions reported holding it in 13F filings for Q2 2026, worth $175.1M in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Fennec Pharmaceuticals Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 78 | 84 | +6 |
| Shares | 13.6M | 13.9M | +263.4K (+1.9%) |
| Value | $112.9M | $129.8M | +$16.9M (+15.0%) |
New holders (11)
Institutions that held Fennec Pharmaceuticals Inc. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| XTX Topco Ltd | 21,247 | $198.9K | 0.01% |
| Quadrature Capital Ltd | 15,321 | $143.6K | 0.00% |
| Acadian Asset Management LLC | 10,708 | $100.0K | 0.00% |
| Renaissance Technologies LLC | 10,600 | $99.2K | 0.00% |
| Alliancebernstein L.P. | 10,310 | $96.5K | 0.00% |
| STRS Ohio | 5,200 | $48.7K | 0.00% |
| Farther Finance Advisors, LLC | 274 | $2.56K | 0.00% |
| SRS Capital Advisors, Inc. | 188 | $1.76K | 0.00% |
| Sunbelt Securities, Inc. | 7 | $66 | 0.00% |
| Federation des caisses Desjardins du Quebec | 6 | $54 | 0.00% |
| SBI Securities Co., Ltd. | 1 | $9 | 0.00% |
Sold out (5)
Institutions that held Fennec Pharmaceuticals Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| EAM Investors, LLC | 78,661 | $652.9K |
| Manatuck Hill Partners, LLC | 30,200 | $250.7K |
| Deutsche Bank AG | 22,328 | $185.3K |
| Sherbrooke Park Advisers LLC | 13,742 | $114.1K |
| HRT Financial LP | 12,395 | $102.0K |